5Hofman J, Skarka A, Havrankova J, et al. Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases[J]. Biochem Pharmacol, 2015, 96 (3) 168 -178.
6Kim KY, Kim SH, Yu SN, et al. Salinomycin enhances doxo- rubiein-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin [J]. Mol MedRep, 2015, 12(2):1898-1904.
7Wushou A, Hou J, Zhao YJ, et al. Twist-1 up-regulation in carcinoma correlates to poor survival [J]. Int J Mol Sci, 2014, 15(12) :21621-21630.
8Lee KW, Yeo SY, Sung CO, et al. Twistl is a key regulator of cancer associated fibroblasts [J]. Cancer Res, 2015, 75(1) :73- 85.
9Vesuna F, Lisok A, Kimble B, et al. Twist contributes to hor- mone resistance in breast cancer by downregulating estrogen re- ceptor-a [J]. Oncogene, 2012, 31(27): 3223-3234.
10Ranganathan S, Halagowder D, Sivasithambaram ND. Querce- tin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells [J]. PLoS One, 2015, 10(10): e0141370.
